Announcements Trials

Browse Landscape

Phase

Phase 2 24 Phase NA 10 Phase 3 7 Phase 4 2 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

OTHER 1 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 439 Neoplasms 364 Breast Neoplasms 261 Colorectal Neoplasms 245 Neoplasm Metastasis 217 Melanoma 210 Leukemia, Myeloid, Acute 188 Multiple Myeloma 187 Pancreatic Neoplasms 183 Ovarian Neoplasms 181 Recurrence 175 Prostatic Neoplasms 161 Lymphoma, Non-Hodgkin 142 Stomach Neoplasms 133 Squamous Cell Carcinoma of Head and Neck 128 Lung Neoplasms 126 Lymphoma 121 Carcinoma, Hepatocellular 117 Carcinoma, Renal Cell 102 Triple Negative Breast Neoplasms 100 Leukemia, Lymphocytic, Chronic, B-Cell 99 Glioblastoma 98 Advanced Solid Tumor 94 Leukemia 93 Small Cell Lung Carcinoma 91 Lymphoma, Large B-Cell, Diffuse 90 Head and Neck Neoplasms 87 Advanced Solid Tumors 85 Endometrial Neoplasms 81 Myelodysplastic Syndromes 78

Interventions

ammonium trichloro(dioxoethylene-O,O'-)tellurate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × INDUSTRY × Warts × Clear all

NCT01555112 2013-08-15

Safety and Efficacy Study to Test Topical AS101 for External Genital Warts

BioMAS Ltd

Phase 1/2 Completed

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡